F Rodriguez-Panadero, A Segado, J Martin Juan, R Ayerbe, I Torres Garcia and J Castillo
Pulmonary Service, Hospital Universitario Virgen del Rocio, Sevilla, Spain.

Diffuse pleural inflammation and fibrin deposition following the instillation of the sclerosing agent is considered necessary for a successful pleural symphysis. We hypothesized that an impairment in fibrin formation or an increased endopleural fibrinolysis would lead to failure of pleurodesis. To investigate changes in the pleural coagulation/fibrinolysis balance, we studied 75 consecutive patients who underwent thoracoscopy. Fifty-four of these patients with malignant pleural effusions and four with a benign recurrent effusion underwent thoracoscopic talc pleurodesis. Another four patients with malignancy and 13 with benign effusions had no talc poudrage performed and were included as a control group. Serial determinations of thrombin- antithrombin III complex (TAT), plasminogen activator inhibitor (PAI), and D-dimer were made in pleural fluid samples taken at the beginning of thoracoscopy (baseline), immediately after thoracoscopic biopsies had been done (postbiopsy), 3 h after thoracoscopy--either with talc poudrage or without--and 24 and 48 h after the procedure, as well as in cases of recurrence of effusions (farline). Successful pleurodesis was obtained in 42 of 52 patients who could be evaluated (81%), and failure was seen in 10. Strong activation of coagulation and production of PAI was observed in all groups, including the control (no talc) group. Fibrinolytic activity (as expressed by D-dimer levels) showed a clear decline 24 h after talc poudrage in patients with a good outcome of pleurodesis, as oppossed to those with bad results and to the control group, and returned to the baseline by 15 d. We conclude that increased pleural fibrinolytic activity is associated with failure of pleurodesis, despite significant inhibitory activity of PAI in all groups.

This article has been cited by other articles:

				S. Gyorik, S. Erni, U. Studler, R. Hodek-Wuerz, M. Tamm, and P. N. Chhajed Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax Eur. Respir. J., April 1, 2007; 29(4): 757 - 760. [Abstract] [Full Text] [PDF]

				G. Clark, M. Licker, D. Bertin, and A. Spiliopoulos Small size new silastic drains: life-threatening hypovolemic shock after thoracic surgery associated with a non-functioning chest tube Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 566 - 568. [Abstract] [Full Text] [PDF]

				J. F. Montes, J. Garcia-Valero, and J. Ferrer Evidence of Innervation in Talc-Induced Pleural Adhesions. Chest, September 1, 2006; 130(3): 702 - 709. [Abstract] [Full Text] [PDF]

				K. Psathakis, E. Calderon-Osuna, B. Romero-Romero, J. Martin-Juan, A. Romero-Falcon, and F. Rodriguez-Panadero The neutrophilic and fibrinolytic response to talc can predict the outcome of pleurodesis. Eur. Respir. J., April 1, 2006; 27(4): 817 - 821. [Abstract] [Full Text] [PDF]

				C. M. Dresler, J. Olak, J. E. Herndon II, W. G. Richards, E. Scalzetti, S. B. Fleishman, K. H. Kernstine, T. Demmy, D. M. Jablons, L. Kohman, et al. Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion Chest, March 1, 2005; 127(3): 909 - 915. [Abstract] [Full Text] [PDF]

				V. B. Antony, N. Nasreen, K. A. Mohammed, P. S. Sriram, W. Frank, N. Schoenfeld, and R. Loddenkemper Talc Pleurodesis: Basic Fibroblast Growth Factor Mediates Pleural Fibrosis Chest, November 1, 2004; 126(5): 1522 - 1528. [Abstract] [Full Text] [PDF]

				J. F. Montes, J. Ferrer, M. A. Villarino, B. Baeza, M. Crespo, and J. Garcia-Valero Influence of Talc Dose on Extrapleural Talc Dissemination after Talc Pleurodesis Am. J. Respir. Crit. Care Med., August 1, 2003; 168(3): 348 - 355. [Abstract] [Full Text] [PDF]

				J. E. Heffner, J. N. Heffner, and L. K. Brown Multilevel and Continuous Pleural Fluid pH Likelihood Ratios for Evaluating Malignant Pleural Effusions Chest, June 1, 2003; 123(6): 1887 - 1894. [Abstract] [Full Text] [PDF]

				G Antunes, E Neville, J Duffy, and N Ali BTS guidelines for the management of malignant pleural effusions Thorax, May 1, 2003; 58(90002): ii29 - 38. [Full Text]

				V.B. Antony Immunological mechanisms in pleural disease Eur. Respir. J., March 1, 2003; 21(3): 539 - 544. [Abstract] [Full Text] [PDF]

				R. W. LIGHT, D.-S. CHENG, Y. C. G.  LEE, J. ROGERS, J. DAVIDSON, and K. B. LANE A Single Intrapleural Injection of Transforming Growth Factor-beta 2 Produces an Excellent Pleurodesis in Rabbits Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 98 - 104. [Abstract] [Full Text]

				J. E. Heffner, P. J. Nietert, and C. Barbieri Pleural Fluid pH as a Predictor of Pleurodesis Failure* : Analysis of Primary Data Chest, January 1, 2000; 117(1): 87 - 95. [Abstract] [Full Text] [PDF]